Special Analysis: Addressing Key Concerns Around the FDA’s Final LDTs Rule
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
Laboratories may have to revise their own medical records disclosure policies to ensure compliance.
Here are the changes to Medicare specimen collection fee and travel allowances included in the 2023 PFS and what you’ll need to know to comply.
One of the biggest danger areas that labs and their billing staffs face in COVID-19 test reimbursement is improper use of HCPCS code G2023.
How to steer clear of assumptions commonly made by employers that can lead to citations under SEC. 1904.32 of the OSHA recordkeeping standard.
Key cases over the past month were the usual FCA-related fare, apart from a dismissed sex discrimination case.
It’s important to have a clear policy in place for approving remote work requests and ensuring employees remain productive.
Federal enforcement actions at the end of October and first two weeks of November featured some unusual characters.
Could not following MAC guidance constitute evidence that a party knowingly submitted, or caused the submission of, false claims?
There are potentially significant legal ramifications of employing digital nomads who work from abroad—for both you and your employee.
What labs and billing managers need to know about multianalyte assays with algorithmic analyses coding for tests based on molecular platforms.